Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Gossamer Bio: Q2 Earnings Snapshot AP - Mon Aug 12, 3:15PM CDT

Gossamer Bio: Q2 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q1 Earnings Snapshot AP - Tue May 7, 4:15PM CDT

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q4 Earnings Snapshot AP - Tue Mar 5, 6:42AM CST

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Gossamer Bio: Q3 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Gossamer Bio: Q2 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q1 Earnings Snapshot AP - Tue May 9, 2023

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio: Q4 Earnings Snapshot AP - Fri Mar 17, 2023

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.9266 (+1.70%)
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update Business Wire - Fri Mar 17, 2023

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation...

GOSS : 0.9266 (+1.70%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire - Mon Feb 6, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS). Such investors...

GOSS : 0.9266 (+1.70%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire - Mon Dec 19, 2022

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS). Such investors...

GOSS : 0.9266 (+1.70%)

Barchart Exclusives

2 Soaring Growth Stocks I'd Buy and Hold Forever Barchart - 31 minutes ago
These two growth stocks represent high-risk, high-reward AI-driven growth opportunities. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot